Search Within

Roni Shouval

Formats
  1. Meeting Abstract (92)
  2. Journal Article (63)
  3. Review (6)
  4. Editorial (4)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (173)
  2. Center for Hematologic Malignancies (112)
  3. Department of Medicine (112)
  4. Bone Marrow Transplant (105)
  5. CTCR Scholars (88)
  6. Survivorship Research (86)

More Groups

People
  1. Miguel-Angel Perales (101)
  2. Michael Scordo (83)
  3. Gunjan Shah (80)
  4. Maria Palomba (75)
  5. Sean Devlin (65)
  6. Parastoo Dahi (64)

More People

Years
  1. 2025 (22)
  2. 2024 (42)
  3. 2023 (49)
  4. 2022 (23)
  5. 2021 (16)
  6. 2020 (15)

More Years

Publications
  1. Blood (65)
  2. Bone Marrow Transplantation (20)
  3. Blood Advances (14)
  4. Transplantation and Cellular Therapy (13)
  5. Biology of Blood and Marrow Transplantation (6)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (80)
  2. Elsevier Inc. (27)
  3. Nature Publishing Group (27)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-apheresis prediction of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rejeski, K.; Hansen, D. K.; Cordas Dos Santos, D. M.; De Menezes Silva Corraes, A.; Castaneda, O.; Dillard, C. M.; Alsdorf, W.; Frenking, J. H.; Purcarea, A.; Chhabra, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR-tography: Longitudinal mapping of CAR-T toxicities across B-cell malignancies reveals biologically distinct and prognostically relevant toxicity phenotypes
    Meeting Abstract

    Rejeski, K.; Fei, T.; Luna, A.; Alhomoud, M.; Valtis, Y. K.; Nishimura, N.; Gomez-Llobell, M.; Accav, N. G.; Beyar-Katz, O.; Raj, S. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center
    Meeting Abstract

    Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Predictors of early safety outcomes with axicabtagene ciloleucel (axi-cel) in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL)
    Meeting Abstract

    Strouse, C.; Farooq, U.; Shouval, R.; Vallurupalli, A.; Moskop, A.; Jacobson, C. A.; Locke, F.; Baird, J. H.; Strati, P.; Patel, D. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes following progression of disease post-CAR-T therapy in relapsed or refractory mantle cell lymphoma: A multicenter analysis
    Meeting Abstract

    Epstein-Peterson, Z. D.; Lionel, A. C.; Joseph, A.; Drill, E.; Atallah-Yunes, S. A.; Brooks, T. R.; Chong, E. A.; Chong, E. R.; Dela Cruz, J.; Frank, M. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparison of acute kidney injury in patients with relapsed or refractory multiple myeloma following CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Farzana, T.; Shaikh, A.; Latcha, S.; Gutgarts, V.; Jurgens, E. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Reduction in platelet counts may predict the development of immune effector cell associated neurotoxicity syndrome in patients receiving CD19 CAR-T cell therapy for relapsed/refractory large B cell lymphoma
    Meeting Abstract

    Khatib, H.; Parizat, A.; Halloun, J.; Shouval, R.; Shibli, N.; Alalouf, O.; Zuckerman, T.; Vahaba, N.; Halamish, I.; Sapir, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Automated grading of immune effector cell-associated hematotoxicity
    Meeting Abstract

    Liang, E.; Rejeski, K.; Raj, S.; Albittar, A.; Huang, J.; Portuguese, A.; Wuliji, N.; Wu, Q.; Torkelson, A.; Kirchmeier, D.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save